Fagron NV

Brussels Stock Exchange FAGR.BR

Fagron NV Gross Profit Margin for the year ending December 31, 2023: 20.45%

Fagron NV Gross Profit Margin is 20.45% for the year ending December 31, 2023, a -51.12% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

Fagron NV Gross Profit Margin for the year ending December 31, 2022 was 41.84%, a -2.99% change year over year.
Fagron NV Gross Profit Margin for the year ending December 31, 2021 was 43.13%, a -2.81% change year over year.
Fagron NV Gross Profit Margin for the year ending December 31, 2020 was 44.38%, a -1.14% change year over year.
Fagron NV Gross Profit Margin for the year ending December 31, 2019 was 44.89%, a 1.65% change year over year.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

Brussels Stock Exchange: FAGR.BR

Fagron NV

CEO	Mr. Rafael Padilla
IPO Date	Oct. 5, 2007
Location	Belgium
Headquarters	Venecoweg 20A
Employees	3,647
Sector	Health Care
Industries Pharmaceuticals

Description

Fagron NV, a pharmaceutical compounding company, provides personalized medicine care to hospitals, pharmacies, clinics, and patients. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. In addition, it supplies raw materials, utensils and equipment, semi-finished products, vehicles, and sterile and non-sterile compounded medicines. Further, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. It has operations in Latin America, North America, Europe, the Middle East, and Africa. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.

Key trends

Past 5 years